This application is related to U.S. patent application Ser. No. 10/906,349, entitled “Method for Treating a Substrate With a High Pressure Fluid Using a Peroxide-Based Process Chemistry,” filed on even date herewith; U.S. patent application Ser. No. 10/987,067, entitled “Method and System for Treating a Substrate Using a Supercritical Fluid,” filed on Nov. 12, 2004; U.S. patent application Ser. No. 10/987,066, entitled “Method and System for Cooling a Pump,” filed on Nov. 12, 2004; U.S. Pat. application Ser. No. 10/987,594, entitled “A Method for Removing a Residue From a Substrate Using Supercritical Carbon Dioxide Processing,” filed on Nov. 12, 2004; and U.S. patent application Ser. No. 10/987,676, entitled “A System for Removing a Residue From a Substrate Using Supercritical Carbon Dioxide Processing,” filed on Nov. 12, 2004. The entire contents of these applications are herein incorporated by reference in their entirety.
The present invention relates to a method and system for treating a substrate in a high pressure processing system and, more particularly, to a method and system for treating a substrate using a high pressure fluid and a process chemistry comprising fluorosilicic acid in a high pressure processing system.
During the fabrication of semiconductor devices for integrated circuits (ICs), a sequence of material processing steps, including both pattern etching and deposition processes, are performed, whereby material is removed from or added to a substrate surface, respectively. During, for instance, pattern etching, a pattern formed in a mask layer of radiation-sensitive material, such as photoresist, using for example photolithography, is transferred to an underlying thin material film using a combination of physical and chemical processes to facilitate the selective removal of the underlying material film relative to the mask layer.
Thereafter, the remaining radiation-sensitive material, or photoresist, and post-etch residue, such as hardened photoresist and other etch residues, are removed using one or more cleaning processes. Conventionally, these residues are removed by performing plasma ashing in an oxygen plasma, followed by wet cleaning through immersion of the substrate in a liquid bath of stripper chemicals.
Until recently, dry plasma ashing and wet cleaning were found to be sufficient for removing residue and contaminants accumulated during semiconductor processing. However, recent advancements for ICs include a reduction in the critical dimension for etched features below a feature dimension acceptable for wet cleaning, such as a feature dimension below approximately 45 to 65 nanometers (nm). Moreover, the advent of new materials, such as low dielectric constant (low-k) materials, limits the use of plasma ashing due to their susceptibility to damage during plasma exposure.
Therefore, at present, interest has developed for the replacement of dry plasma ashing and wet cleaning. One interest includes the development of dry cleaning systems utilizing a supercritical fluid as a carrier for a solvent, or other residue removing composition. At present, the inventors have recognized that conventional processes are deficient in, for example, cleaning residue from a substrate, particularly those substrates following complex etching processes, or having high aspect ratio features.
The present invention provides a method and system for treating a substrate with a high pressure fluid and a process chemistry in a high pressure processing system. In one embodiment of the invention, there is provided a method and system for treating a substrate with a high pressure fluid and a process chemistry comprising fluorosilicic acid in a high pressure processing system.
According to another embodiment, the method includes placing the substrate in a high pressure processing chamber onto a platen configured to support the substrate; forming a supercritical fluid from a fluid by adjusting a pressure of the fluid above the critical pressure of the fluid, and adjusting a temperature of the fluid above the critical temperature of the fluid; introducing the supercritical fluid to the high pressure processing chamber; introducing a process chemistry comprising fluorosilicic acid to the supercritical fluid; and exposing the substrate to the supercritical fluid and process chemistry.
According to yet another embodiment, the high pressure processing system includes a processing chamber configured to treat the substrate; a platen coupled to the processing chamber, and configured to support the substrate; a high pressure fluid supply system configured to introduce a supercritical fluid to the processing chamber; a fluid flow system coupled to the processing chamber, and configured to flow the supercritical fluid over the substrate in the processing chamber; a process chemistry supply system having a source of fluorosilicic acid and an injection system configured to introduce a process chemistry comprising fluorosilicic acid to the processing chamber; and a temperature control system coupled to one or more of the processing chamber, the platen, the high pressure fluid supply system, the fluid flow system, and the process chemistry supply system, and configured to elevate the supercritical fluid to a temperature approximately equal to 40° C., or greater.
In the accompanying drawings:
In the following description, to facilitate a thorough understanding of the invention and for purposes of explanation and not limitation, specific details are set forth, such as a particular geometry of the processing system and various descriptions of the system components. However, it should be understood that the invention may be practiced with other embodiments that depart from these specific details.
Referring now to the drawings, wherein like reference numerals designate identical or corresponding parts throughout the several views,
Alternately, or in addition, controller 150 can be coupled to a one or more additional controllers/computers (not shown), and controller 150 can obtain setup and/or configuration information from an additional controller/computer.
In
The controller 150 can be used to configure any number of processing elements (110, 120, 130, and 140), and the controller 150 can collect, provide, process, store, and display data from processing elements. The controller 150 can comprise a number of applications for controlling one or more of the processing elements. For example, controller 150 can include a graphic user interface (GUI) component (not shown) that can provide easy to use interfaces that enable a user to monitor and/or control one or more processing elements.
Referring still to
Some components, such as a fluid flow or recirculation pump, may require cooling in order to permit proper functioning. For example, some commercially available pumps, having specifications required for processing performance at high pressure and cleanliness during supercritical processing, comprise components that are limited in temperature. Therefore, as the temperature of the fluid and structure are elevated, cooling of the pump is required to maintain its functionality. Fluid flow system 120 for circulating the supercritical fluid through processing chamber 110 can comprise a primary flow line 620 coupled to high pressure processing chamber 110, and configured to supply the supercritical fluid at a fluid temperature above the critical temperature of the fluid, for example equal to or greater than 40° C., to the high pressure processing chamber 110, and a high temperature pump 600, shown and described below with reference to
As illustrated in
Alternatively, as illustrated in
Additional details regarding pump design are provided in co-pending U.S. patent application Ser. No. 10/987,066, entitled “Method and System for Cooling a Pump,” the entire content of which is herein incorporated by reference in its entirety.
Referring again to
As described above, the fluid supply system 140 can include a supercritical fluid supply system, which can be a carbon dioxide supply system. For example, the fluid supply system 140 can be configured to introduce a high pressure fluid having a pressure substantially near the critical pressure for the fluid. Additionally, the fluid supply system 140 can be configured to introduce a supercritical fluid, such as carbon dioxide in a supercritical state. Additionally, for example, the fluid supply system 140 can be configured to introduce a supercritical fluid, such as supercritical carbon dioxide, at a pressure ranging from approximately the critical pressure of carbon dioxide to 10,000 psi. Examples of other supercritical fluid species useful in the broad practice of the invention include, but are not limited to, carbon dioxide (as described above), oxygen, argon, krypton, xenon, ammonia, methane, methanol, dimethyl ketone, hydrogen, water, and sulfur hexafluoride. The fluid supply system can, for example, comprise a carbon dioxide source (not shown) and a plurality of flow control elements (not shown) for generating a supercritical fluid. For example, the carbon dioxide source can include a CO2 feed system, and the flow control elements can include supply lines, valves, filters, pumps, and heaters. The fluid supply system 140 can comprise an inlet valve (not shown) that is configured to open and close to allow or prevent the stream of supercritical carbon dioxide from flowing into the processing chamber 110. For example, controller 150 can be used to determine fluid parameters such as pressure, temperature, process time, and flow rate.
Referring still to
The process chemistry supply system 130 can be configured to introduce one or more of the following process compositions, but not limited to: cleaning compositions for removing contaminants, residues, hardened residues, photoresist, hardened photoresist, post-etch residue, post-ash residue, post chemical-mechanical polishing (CMP) residue, post-polishing residue, or post-implant residue, or any combination thereof; cleaning compositions for removing particulate; drying compositions for drying thin films, porous thin films, porous low dielectric constant materials, or air-gap dielectrics, or any combination thereof; film-forming compositions for preparing dielectric thin films, metal thin films, or any combination thereof; healing compositions for restoring the dielectric constant of low dielectric constant (low-k) films; sealing compositions for sealing porous films; or any combination thereof. Additionally, the process chemistry supply system 130 can be configured to introduce solvents, co-solvents, surfactants, etchants, acids, bases, chelators, oxidizers, film-forming precursors, or reducing agents, or any combination thereof.
The process chemistry supply system 130 can be configured to introduce N-methyl pyrrolidone (NMP), diglycol amine, hydroxyl amine, di-isopropyl amine, tri-isopropyl amine, tertiary amines, catechol, ammonium fluoride, ammonium bifluoride, methylacetoacetamide, ozone, propylene glycol monoethyl ether acetate, acetylacetone, dibasic esters, ethyl lactate, CHF3, BF3, HF, other fluorine containing chemicals, or any mixture thereof. Other chemicals such as organic solvents may be utilized independently or in conjunction with the above chemicals to remove organic materials. The organic solvents may include, for example, an alcohol, ether, and/or glycol, such as acetone, diacetone alcohol, dimethyl sulfoxide (DMSO), ethylene glycol, methanol, ethanol, propanol, or isopropanol (IPA). For further details, see U.S. Pat. No. 6,306,564B1, filed May 27, 1998, and titled “REMOVAL OF RESIST OR RESIDUE FROM SEMICONDUCTORS USING SUPERCRITICAL CARBON DIOXIDE,” and U.S. Pat. No. 6,509,141B2, filed Sep. 3, 1999, and titled “REMOVAL OF PHOTORESIST AND PHOTORESIST RESIDUE FROM SEMICONDUCTORS USING SUPERCRITICAL CARBON DIOXIDE PROCESS,” both incorporated by reference herein.
Additionally, the process chemistry supply system 130 can comprise a cleaning chemistry assembly (not shown) for providing cleaning chemistry for generating supercritical cleaning solutions within the processing chamber. The cleaning chemistry can include peroxides and a fluoride source. For example, the peroxides can include hydrogen peroxide, benzoyl peroxide, or any other suitable peroxide, and the fluoride sources can include fluoride salts (such as ammonium fluoride salts), hydrogen fluoride, fluoride adducts (such as organo-ammonium fluoride adducts), and combinations thereof. Further details of fluoride sources and methods of generating supercritical processing solutions with fluoride sources are described in U.S. patent application Ser. No. 10/442,557, filed May 20, 2003, and titled “TETRA-ORGANIC AMMONIUM FLUORIDE AND HF IN SUPERCRITICAL FLUID FOR PHOTORESIST AND RESIDUE REMOVAL,” and U.S. patent application Ser. No. 10/321,341, filed Dec. 16, 2002, and titled “FLUORIDE IN SUPERCRITICAL FLUID FOR PHOTORESIST POLYMER AND RESIDUE REMOVAL,” both incorporated by reference herein.
Furthermore, the process chemistry supply system 130 can be configured to introduce chelating agents, complexing agents and other oxidants, organic and inorganic acids that can be introduced into the supercritical fluid solution with one or more carrier solvents, such as N,N-dimethylacetamide (DMAc), gamma-butyrolactone (BLO), dimethyl sulfoxide (DMSO), ethylene carbonate (EC), butylenes carbonate (BC), propylene carbonate (PC), N-methyl pyrrolidone (NMP), dimethylpiperidone, propylene carbonate, and alcohols (such a methanol, ethanol and 2-propanol).
Moreover, the process chemistry supply system 130 can comprise a rinsing chemistry assembly (not shown) for providing rinsing chemistry for generating supercritical rinsing solutions within the processing chamber. The rinsing chemistry can include one or more organic solvents including, but not limited to, alcohols and ketone. In one embodiment, the rinsing chemistry can comprise sulfolane, also known as thiocyclopentane-1,1-dioxide, (cyclo)tetramethylene sulphone and 2,3,4,5-tetrahydrothiophene-1,1-dioxide, which can be purchased from a number of venders, such as Degussa Stanlow Limited, Lake Court, Hursley Winchester SO21 2LD UK.
Moreover, the process chemistry supply system 130 can be configured to introduce treating chemistry for curing, cleaning, healing (or restoring the dielectric constant of low-k materials), or sealing, or any combination, low dielectric constant films (porous or non-porous). The chemistry can include hexamethyidisilazane (HMDS), chlorotrimethylsilane (TMCS), trichloromethylsilane (TCMS), dimethylsilyldiethylamine (DMSDEA), tetramethyldisilazane (TMDS), trimethylsilyldimethylamine (TMSDMA), dimethylsilyldimethylamine (DMSDMA), trimethylsilyldiethylamine (TMSDEA), bistrimethylsilyl urea (BTSU), bis(dimethylamino)methyl silane (B[DMA]MS), bis (dimethylamino)dimethyl silane (B[DMA]DS), HMCTS, dimethylaminopentamethyldisilane (DMAPMDS), dimethylaminodimethyldisilane (DMADMDS), disila-aza-cyclopentane (TDACP), disila-oza-cyclopentane (TDOCP), methyltrimethoxysilane (MTMOS), vinyltrimethoxysilane (VTMOS), or trimethylsilylimidazole (TMSI). Additionally, the chemistry may include N-tert-butyl-1,1-dimethyl-1-(2,3,4,5-tetramethyl-2,4-cyclopentadiene-1-yl)silanamine, 1,3-diphenyl-1,1,3,3-tetramethy or tert-butylchlorodiphenylsilane. For further details, see U.S. patent application Ser. No. 10/682,196, filed Oct. 10, 2003, and titled “METHOD AND SYSTEM FOR TREATING A DIELECTRIC FILM,” and U.S. patent application Ser. No. 10/379,984, filed Mar. 4, 2003, and titled “METHOD OF PASSIVATING LOW DIELECTRIC MATERIALS IN WAFER PROCESSING,” both incorporated by reference herein.
Moreover, the process chemistry supply system 130 can be configured to introduce a peroxide during, for instance, cleaning processes. The peroxide can be introduced with any one of the above process chemistries, or any mixture thereof. The peroxide can include organic peroxides, or inorganic peroxides, or a combination thereof. For example, organic peroxides can include 2-butanone peroxide; 2,4-pentanedione peroxide; peracetic acid; t-butyl hydroperoxide; benzoyl peroxide; or m-chloroperbenzoic acid (mCPBA). Other peroxides can include hydrogen peroxide. Alternatively, the peroxide can include a diacyl peroxide, such as: decanoyl peroxide; lauroyl peroxide; succinic acid peroxide; or benzoyl peroxide; or any combination thereof. Alternatively, the peroxide can include a dialkyl peroxide, such as: dicumyl peroxide; 2,5-di(t-butylperoxy)-2,5-dimethylhexane; t-butyl cumyl peroxide; α,α-bis(t-butylperoxy)diisopropylbenzene mixture of isomers; di(t-amyl) peroxide; di(t-butyl) peroxide; or 2,5-di(t-butylperoxy)-2,5-dimethyl-3-hexyne; or any combination thereof. Alternatively, the peroxide can include a diperoxyketal, such as: 1,1-di(t-butylperoxy)-3,3,5-trimethylcyclohexane; 1,1-di(t-butylperoxy)cyclohexane; 1,1-di(t-amylperoxy)-cyclohexane; n-butyl 4,4-di(t-butylperoxy)valerate; ethyl 3,3-di-(t-amylperoxy)butanoate; t-butyl peroxy-2-ethylhexanoate; or ethyl 3,3-di(t-butylperoxy)butyrate; or any combination thereof. Alternatively, the peroxide can include a hydroperoxide, such as: cumene hydroperoxide; or t-butyl hydroperoxide; or any combination thereof. Alternatively, the peroxide can include a ketone peroxide, such as: methyl ethyl ketone peroxide; or 2,4-pentanedione peroxide; or any combination thereof. Alternatively, the peroxide can include a peroxydicarbonate, such as: di(n-propyl)peroxydicarbonate; di(sec-butyl)peroxydicarbonate; or di(2-ethylhexyl)peroxydicarbonate; or any combination thereof. Alternatively, the peroxide can include a peroxyester, such as: 3-hydroxyl-1,1-dimethylbutyl peroxyneodecanoate; α-cumyl peroxyneodecanoate; t-amyl peroxyneodecanoate; t-butyl peroxyneodecanoate; t-butyl peroxypivalate; 2,5-di(2-ethylhexanoylperoxy)-2,5-dimethylhexane; t-amyl peroxy-2-ethylhexanoate; t-butyl peroxy-2-ethylhexanoate; t-amyl peroxyacetate; t-butyl peroxyacetate; t-butyl peroxybenzoate; OO-(t-amyl) O-(2-ethylhexyl)monoperoxycarbonate; OO-(t-butyl) O-isopropyl monoperoxycarbonate; OO-(t-butyl) O-(2-ethylhexyl)monoperoxycarbonate; polyether poly-t-butylperoxy carbonate; or t-butyl peroxy-3,5,5-trimethylhexanoate; or any combination thereof. Alternatively, the peroxide can include any combination of peroxides listed above.
In accordance with one embodiment of the present invention, the process chemistry supply system 130 is configured to introduce fluorosilicic acid. Alternatively, the process chemistry supply system is configured to introduce fluorosilicic acid with a solvent, a co-solvent, a surfactant, an acid, a base, a peroxide, or an etchant. Alternatively, the fluorosilicic acid can be introduced in combination with any of the chemicals presented above. For example, fluorosilicic acid can be introduced with N,N-dimethylacetamide (DMAc), gamma-butyrolactone (BLO), dimethyl sulfoxide (DMSO), ethylene carbonate (EC), butylene carbonate (BC), propylene carbonate (PC), N-methyl pyrrolidone (NMP), dimethylpiperidone, propylene carbonate, or an alcohol (such a methanol (MeOH), isopropyl alcohol (IPA), or ethanol).
The processing chamber 110 can be configured to process substrate 105 by exposing the substrate 105 to fluid from the fluid supply system 140 and process chemistry from the process chemistry supply system 130 in a processing space 112. Additionally, processing chamber 110 can include an upper chamber assembly 114, and a lower chamber assembly 115.
The upper chamber assembly 112 can comprise a heater (not shown) for heating the processing chamber 110, the substrate 105, or the processing fluid, or a combination of two or more thereof. Alternately, a heater is not required. Additionally, the upper chamber assembly 112 can include flow components for flowing a processing fluid through the processing chamber 110. In one example, a circular flow pattern can be established. Alternately, the flow components for flowing the fluid can be configured differently to affect a different flow pattern. Alternatively, the upper chamber assembly 112 can be configured to fill the processing chamber 110.
The lower chamber assembly 115 can include a platen 116 configured to support substrate 105 and a drive mechanism 118 for translating the platen 116 in order to load and unload substrate 105, and seal lower chamber assembly 115 with upper chamber assembly 114. The platen 116 can also be configured to heat or cool the substrate 105 before, during, and/or after processing the substrate 105. For example, the platen 116 can include one or more heater rods configured to elevate the temperature of the platen to approximately 31° C. or greater. Additionally, the lower assembly 115 can include a lift pin assembly for displacing the substrate 105 from the upper surface of the platen 116 during substrate loading and unloading.
Additionally, controller 150 includes a temperature control system coupled to one or more of the processing chamber 110, the fluid flow system 120 (or recirculation system), the platen 116, the high pressure fluid supply system 140, or the process chemistry supply system 130. The temperature control system is coupled to heating elements embedded in one or more of these systems, and configured to elevate and maintain the temperature of the supercritical fluid to above the fluid's critical temperature, for example, approximately 31° C. or greater. The heating elements can, for example, include resistive heating elements.
A transfer system (not shown) can be used to move a substrate into and out of the processing chamber 110 through a slot (not shown). In one example, the slot can be opened and closed by moving the platen 116, and in another example, the slot can be controlled using a gate valve (not shown).
The substrate can include semiconductor material, metallic material, dielectric material, ceramic material, or polymer material, or a combination of two or more thereof. The semiconductor material can include Si, Ge, Si/Ge, or GaAs. The metallic material can include Cu, Al, Ni, Pb, Ti, and/or Ta. The dielectric material can include silica, silicon dioxide, quartz, aluminum oxide, sapphire, low dielectric constant materials, Teflon®, and/or polyimide. The ceramic material can include aluminum oxide, silicon carbide, etc.
The processing system 100 can also comprise a pressure control system (not shown). The pressure control system can be coupled to the processing chamber 110, but this is not required. In alternate embodiments, the pressure control system can be configured differently and coupled differently. The pressure control system can include one or more pressure valves (not shown) for exhausting the processing chamber 110 and/or for regulating the pressure within the processing chamber 110. Alternately, the pressure control system can also include one or more pumps (not shown). For example, one pump may be used to increase the pressure within the processing chamber, and another pump may be used to evacuate the processing chamber 110. In another embodiment, the pressure control system can comprise seals for sealing the processing chamber. In addition, the pressure control system can comprise an elevator for raising and lowering the substrate 105 and/or the platen 116.
Furthermore, the processing system 100 can comprise an exhaust control system. The exhaust control system can be coupled to the processing chamber 110, but this is not required. In alternate embodiments, the exhaust control system can be configured differently and coupled differently. The exhaust control system can include an exhaust gas collection vessel (not shown) and can be used to remove contaminants from the processing fluid. Alternately, the exhaust control system can be used to recycle the processing fluid.
Referring now to
As shown in
Additional details regarding injection of process chemistry are provided in co-pending U.S. patent application Ser. No. 10/957,417, filed Oct. 1, 2004 entitled “Method and System for Injecting Chemistry into a Supercritical Fluid,” the entire content of which is herein incorporated by reference in its entirety.
Furthermore, the fluid supply system 240 can include a supercritical fluid source 242, a pumping system 244, and a supercritical fluid heater 246. In addition, one or more injection valves, and/or exhaust valves may be utilized with the fluid supply system 240.
The processing chamber 210 can be configured to process substrate 205 by exposing the substrate 205 to fluid from the fluid supply system 240 and process chemistry from the process chemistry supply system 230 in a processing space 212. Additionally, processing chamber 210 can include an upper chamber assembly 214, and a lower chamber assembly 215 having a platen 216 and drive mechanism 218, as described above with reference to
Alternatively, the processing chamber 210 can be configured as described in pending U.S. patent application Ser. No. 09/912,844 (U.S. Patent Application Publication No. 2002/0046707 A1), entitled “High Pressure Processing Chamber for Semiconductor Substrates,” and filed on Jul. 24, 2001, which is incorporated herein by reference in its entirety. For example,
As described above with reference to
Additionally, the fluid, such as supercritical carbon dioxide, exits the processing chamber adjacent a surface of the substrate through one or more outlets (not shown). For example, as described in U.S. patent application Ser. No. 09/912,844, the one or more outlets can include two outlet holes positioned proximate to and above the center of substrate 305. The flow through the two outlets can be alternated from one outlet to the next outlet using a shutter valve.
Alternatively, the fluid, such as supercritical carbon dioxide, can enter and exit from the processing chamber 110 as described in pending U.S. patent application Ser. No. 10/018,922, filed Dec. 20, 2004 entitled “Method and System for Flowing a Supercritical Fluid in a High Pressure Processing System,” the entire content of which is herein incorporated by reference in its entirety.
Referring now to
In 720, a supercritical fluid is formed by bringing a fluid to a supercritical state by adjusting the pressure of the fluid to at or above the critical pressure of the fluid, and adjusting the temperature of the fluid to at or above the critical temperature of the fluid. In 730, the supercritical fluid is introduced to the high pressure processing chamber through one or more inlets and discharged through one or more outlets. The temperature of the supercritical fluid may be elevated to a value equal to or greater than 40° C. In one embodiment, the temperature of the supercritical fluid is elevated to greater than 80° C. to form a high temperature supercritical fluid. In a further embodiment, the temperature of the supercritical fluid is set to equal or greater than 120° C.
In 740, a process chemistry comprising fluorosilicic acid is introduced to the supercritical fluid. The fluorosilicic acid can, for example, be introduced with any one or combination of chemicals presented above. In 750, the substrate is exposed to the supercritical fluid and process chemistry.
Additionally, as described above, the process chemistry can comprise a cleaning composition, a film forming composition, a healing composition, or a sealing composition, or any combination thereof. For example, the process chemistry can comprise a cleaning composition containing fluorosilicic acid. In each of the following examples, the temperature of the supercritical fluid is elevated above approximately 40° C. and is, for example, 135° C. Furthermore, in each of the following examples, the pressure of the supercritical fluid is above the critical pressure and is, for instance, 2900 psi. In one example, the cleaning composition can comprise fluorosilicic acid combined with, for instance, N-methyl pyrrolidone (NMP) in supercritical carbon dioxide. By way of further example, a process recipe for removing post-etch residue(s) can comprise two steps including: (1) exposure of the substrate to a mixture of 200 microliters of fluorosilicic acid and 13 milliliters of NMP in supercritical carbon dioxide for approximately three minutes; and (2) exposure of the substrate to 13 milliliters of NMP in supercritical carbon dioxide for approximately three minutes. The first step can be repeated any number of times. Moreover, any step may be repeated. Additionally, the time duration for each step, or sub-step, may be varied greater than or less than those specified. Further yet, the amount of any chemical in the process chemistry may be varied greater than or less than those specified, and the ratios may be varied. Further yet, the temperature or pressure can be varied.
In another example, the process chemistry can comprise a first cleaning composition comprising a mixture of fluorosilicic acid and gamma-butyrolactone (BLO) in supercritical carbon dioxide, and a second cleaning composition comprising a mixture of fluorosilicic acid and isopropyl alcohol (IPA) in supercritical carbon dioxide. By way of further example, a process recipe for removing post-etch residue(s) can comprise three steps including: (1) exposure of the substrate to 10 milliliters of gamma-butyrolactone (BLO) and 200 microliters of fluorosilicic acid in supercritical carbon dioxide for approximately three minutes; (2) exposure of the substrate to 10 milliliters of isopropyl alcohol (IPA) and 200 microliters of fluorosilicic acid in supercritical carbon dioxide for approximately three minutes; and (3) exposure of the substrate to 13 milliliters of 12:1 ratio MeOH:H2O in supercritical carbon dioxide for approximately three minutes. The first, second, and third steps can be repeated any number of times. Moreover, any step may be repeated. Additionally, the time duration for each step, or sub-step, may be varied greater than or less than those specified. Further yet, the amount of any chemical in the process chemistry may be varied greater than or less than those specified, and the ratios may be varied. Further yet, the temperature or pressure can be varied.
In another example, the process chemistry can comprise a first cleaning composition comprising a mixture of fluorosilicic acid and gamma-butyrolactone (BLO) in supercritical carbon dioxide, and a second cleaning composition comprising a mixture of fluorosilicic acid and isopropyl alcohol (IPA) in supercritical carbon dioxide, and a third cleaning composition comprising 2-butanone peroxide in supercritical carbon dioxide. By way of further example, a process recipe for removing post-etch residue(s) can comprise three steps including: (1) exposure of the substrate to 10 milliliters of gamma-butyrolactone (BLO) and 200 microliters of fluorosilicic acid in supercritical carbon dioxide for approximately three minutes; (2) exposure of the substrate to 10 milliliters of isopropyl alcohol (IPA) and 200 microliters of fluorosilicic acid in supercritical carbon dioxide for approximately three minutes; and (3) exposure of the substrate to 13 milliliters of 2-butanone peroxide in supercritical carbon dioxide for approximately three minutes. The first, second, and third steps can be repeated any number of times, for instance, they may be repeated once. Moreover, any step may be repeated. Additionally, the time duration for each step, or sub-step, may be varied greater than or less than those specified. Further yet, the amount of any chemical in the process chemistry may be varied greater than or less than those specified, and the ratios may be varied. Further yet, the temperature or pressure can be varied.
Additional details regarding high temperature processing are provided in co-pending U.S. patent application Ser. No. 10/987,067, entitled “Method and System For Treating a Substrate Using a Supercritical Fluid,” filed on Nov. 12, 2004; the entire content of which is herein incorporated by reference in its entirety.
In yet another embodiment, the processes described herein can be further supplemented by ozone processing. For example, when performing a cleaning process, the substrate can be subjected to ozone treatment prior to by treating with a supercritical processing solution. During ozone treatment, the substrate enters an ozone module, and the surface residues to be removed are exposed to an ozone atmosphere. For instance, a partial pressure of ozone formed in oxygen can be flowed over the surface of the substrate for a period of time sufficient to oxidize residues either partly or wholly. The ozone process gas flow rate can, for example, range from 1 to 50 slm (standard liters per minute) and, by way of further example, the flow rate can range from 5 to 15 slm. Additionally, the pressure can, for example, range from 1 to 5 atm and, by way of further example, range from 1 to 3 atm. Further details are provided in co-pending U.S. patent application Ser. No. 10/987,594, entitled “A Method for Removing a Residue from a Substrate Using Supercritical Carbon Dioxide Processing,” filed on Nov. 12, 2004, and co-pending U.S. patent application Ser. No. 10/987,676, entitled “A System for Removing a Residue from a Substrate Using Supercritical Carbon Dioxide Processing,” filed on Nov. 12, 2004; the entire contents of which are incorporated herein by reference in their entirety.
Although only certain exemplary embodiments of this invention have been described in detail above, those skilled in the art will readily appreciate that many modifications are possible in the exemplary embodiments without materially departing from the novel teachings and advantages of this invention. Accordingly, all such modifications are intended to be included within the scope of this invention.
Number | Name | Date | Kind |
---|---|---|---|
2439689 | Hyde | Apr 1948 | A |
2617719 | Stewart | Nov 1952 | A |
2625886 | Browne | Jan 1953 | A |
3642020 | Payne | Feb 1972 | A |
3744660 | Gaines et al. | Jul 1973 | A |
3890176 | Bolon | Jun 1975 | A |
3900551 | Bardoncelli et al. | Aug 1975 | A |
3968885 | Hassan et al. | Jul 1976 | A |
4029517 | Rand | Jun 1977 | A |
4091643 | Zucchini | May 1978 | A |
4219333 | Harris | Aug 1980 | A |
4245154 | Uehara et al. | Jan 1981 | A |
4341592 | Shortes et al. | Jul 1982 | A |
4349415 | DeFilippi et al. | Sep 1982 | A |
4355937 | Mack et al. | Oct 1982 | A |
4367140 | Wilson | Jan 1983 | A |
4406596 | Budde | Sep 1983 | A |
4422651 | Platts | Dec 1983 | A |
4474199 | Blaudszun | Oct 1984 | A |
4475993 | Blander et al. | Oct 1984 | A |
4522788 | Sitek et al. | Jun 1985 | A |
4549467 | Wilden et al. | Oct 1985 | A |
4592306 | Gallego | Jun 1986 | A |
4601181 | Privat | Jul 1986 | A |
4626509 | Lyman | Dec 1986 | A |
4670126 | Messer et al. | Jun 1987 | A |
4682937 | Credle, Jr. | Jul 1987 | A |
4693777 | Hazano et al. | Sep 1987 | A |
4749440 | Blackwood et al. | Jun 1988 | A |
4778356 | Hicks | Oct 1988 | A |
4788043 | Kagiyama et al. | Nov 1988 | A |
4789077 | Noe | Dec 1988 | A |
4823976 | White, III et al. | Apr 1989 | A |
4825808 | Takahashi et al. | May 1989 | A |
4827867 | Takei et al. | May 1989 | A |
4838476 | Rahn | Jun 1989 | A |
4865061 | Fowler et al. | Sep 1989 | A |
4877530 | Moses | Oct 1989 | A |
4879004 | Oesch et al. | Nov 1989 | A |
4879431 | Bertoncini | Nov 1989 | A |
4917556 | Stark et al. | Apr 1990 | A |
4923828 | Gluck et al. | May 1990 | A |
4924892 | Kiba et al. | May 1990 | A |
4925790 | Blanch et al. | May 1990 | A |
4933404 | Beckman et al. | Jun 1990 | A |
4944837 | Nishikawa et al. | Jul 1990 | A |
4951601 | Maydan et al. | Aug 1990 | A |
4960140 | Ishijima et al. | Oct 1990 | A |
4983223 | Gessner | Jan 1991 | A |
5011542 | Weil | Apr 1991 | A |
5013366 | Jackson et al. | May 1991 | A |
5044871 | Davis et al. | Sep 1991 | A |
5062770 | Story et al. | Nov 1991 | A |
5068040 | Jackson | Nov 1991 | A |
5071485 | Matthews et al. | Dec 1991 | A |
5091207 | Tanaka | Feb 1992 | A |
5105556 | Kurokawa et al. | Apr 1992 | A |
5143103 | Basso et al. | Sep 1992 | A |
5158704 | Fulton et al. | Oct 1992 | A |
5167716 | Boitnott et al. | Dec 1992 | A |
5169296 | Wilden | Dec 1992 | A |
5169408 | Biggerstaff et al. | Dec 1992 | A |
5174917 | Monzyk | Dec 1992 | A |
5185058 | Cathey, Jr. | Feb 1993 | A |
5185296 | Morita et al. | Feb 1993 | A |
5186594 | Toshima et al. | Feb 1993 | A |
5186718 | Tepman et al. | Feb 1993 | A |
5188515 | Horn | Feb 1993 | A |
5190373 | Dickson et al. | Mar 1993 | A |
5191993 | Wanger et al. | Mar 1993 | A |
5193560 | Tanaka et al. | Mar 1993 | A |
5195878 | Sahiavo et al. | Mar 1993 | A |
5196134 | Jackson | Mar 1993 | A |
5201960 | Starov | Apr 1993 | A |
5213485 | Wilden | May 1993 | A |
5213619 | Jackson et al. | May 1993 | A |
5215592 | Jackson | Jun 1993 | A |
5217043 | Novakovi | Jun 1993 | A |
5221019 | Pechacek et al. | Jun 1993 | A |
5222876 | Budde | Jun 1993 | A |
5224504 | Thompson et al. | Jul 1993 | A |
5225173 | Wai | Jul 1993 | A |
5236602 | Jackson | Aug 1993 | A |
5236669 | Simmons et al. | Aug 1993 | A |
5237824 | Pawliszyn | Aug 1993 | A |
5238671 | Matson et al. | Aug 1993 | A |
5240390 | Kvinge et al. | Aug 1993 | A |
5243821 | Schuck et al. | Sep 1993 | A |
5246500 | Samata et al. | Sep 1993 | A |
5250078 | Saus et al. | Oct 1993 | A |
5251776 | Morgan, Jr. et al. | Oct 1993 | A |
5261965 | Moslehi | Nov 1993 | A |
5266205 | Fulton et al. | Nov 1993 | A |
5267455 | Dewees et al. | Dec 1993 | A |
5269815 | Schlenker et al. | Dec 1993 | A |
5269850 | Jackson | Dec 1993 | A |
5274129 | Natale et al. | Dec 1993 | A |
5280693 | Heudecker | Jan 1994 | A |
5285352 | Pastore et al. | Feb 1994 | A |
5288333 | Tanaka et al. | Feb 1994 | A |
5290361 | Hayashida et al. | Mar 1994 | A |
5294261 | McDermott et al. | Mar 1994 | A |
5298032 | Schlenker et al. | Mar 1994 | A |
5304515 | Morita et al. | Apr 1994 | A |
5306350 | Hoy et al. | Apr 1994 | A |
5312882 | DeSimone et al. | May 1994 | A |
5313965 | Palen | May 1994 | A |
5314574 | Takahashi | May 1994 | A |
5316591 | Chao et al. | May 1994 | A |
5320742 | Fletcher et al. | Jun 1994 | A |
5328722 | Ghanayem et al. | Jul 1994 | A |
5334332 | Lee | Aug 1994 | A |
5334493 | Fujita et al. | Aug 1994 | A |
5337446 | Smith et al. | Aug 1994 | A |
5339844 | Stanford, Jr. et al. | Aug 1994 | A |
5352327 | Witowski | Oct 1994 | A |
5355901 | Mielnik et al. | Oct 1994 | A |
5356538 | Wai et al. | Oct 1994 | A |
5364497 | Chau et al. | Nov 1994 | A |
5368171 | Jackson | Nov 1994 | A |
5370740 | Chao et al. | Dec 1994 | A |
5370741 | Bergman | Dec 1994 | A |
5370742 | Mitchell et al. | Dec 1994 | A |
5377705 | Smith, Jr. et al. | Jan 1995 | A |
5401322 | Marshall | Mar 1995 | A |
5403621 | Jackson et al. | Apr 1995 | A |
5403665 | Alley et al. | Apr 1995 | A |
5404894 | Shiraiwa | Apr 1995 | A |
5412958 | Iliff et al. | May 1995 | A |
5417768 | Smith, Jr. et al. | May 1995 | A |
5433334 | Reneau | Jul 1995 | A |
5447294 | Sakata et al. | Sep 1995 | A |
5456759 | Stanford, Jr. et al. | Oct 1995 | A |
5470393 | Fukazawa | Nov 1995 | A |
5474812 | Truckenmuller et al. | Dec 1995 | A |
5482564 | Douglas et al. | Jan 1996 | A |
5486212 | Mitchell et al. | Jan 1996 | A |
5494526 | Paranjpe | Feb 1996 | A |
5500081 | Bergman | Mar 1996 | A |
5501761 | Evans et al. | Mar 1996 | A |
5503176 | Dunmire et al. | Apr 1996 | A |
5505219 | Lansberry et al. | Apr 1996 | A |
5509431 | Smith, Jr. et al. | Apr 1996 | A |
5514220 | Wetmore et al. | May 1996 | A |
5522938 | O'Brien | Jun 1996 | A |
5526834 | Mielnik et al. | Jun 1996 | A |
5533538 | Marshall | Jul 1996 | A |
5547774 | Gimzewski et al. | Aug 1996 | A |
5550211 | DeCrosta et al. | Aug 1996 | A |
5571330 | Kyogoku | Nov 1996 | A |
5580846 | Hayashida et al. | Dec 1996 | A |
5589082 | Lin et al. | Dec 1996 | A |
5589105 | DeSimone et al. | Dec 1996 | A |
5589224 | Tepman et al. | Dec 1996 | A |
5618751 | Golden et al. | Apr 1997 | A |
5621982 | Yamashita et al. | Apr 1997 | A |
5629918 | Ho et al. | May 1997 | A |
5632847 | Ohno et al. | May 1997 | A |
5635463 | Muraoka | Jun 1997 | A |
5637151 | Schulz | Jun 1997 | A |
5641887 | Beckman et al. | Jun 1997 | A |
5644855 | McDermott et al. | Jul 1997 | A |
5649809 | Stapelfeldt | Jul 1997 | A |
5656097 | Olesen et al. | Aug 1997 | A |
5665527 | Allen et al. | Sep 1997 | A |
5669251 | Townsend et al. | Sep 1997 | A |
5672204 | Habuka | Sep 1997 | A |
5676705 | Jureller et al. | Oct 1997 | A |
5679169 | Gonzales et al. | Oct 1997 | A |
5679171 | Saga et al. | Oct 1997 | A |
5683473 | Jureller et al. | Nov 1997 | A |
5683977 | Jureller et al. | Nov 1997 | A |
5688879 | DeSimone | Nov 1997 | A |
5700379 | Biebl | Dec 1997 | A |
5702228 | Tamai et al. | Dec 1997 | A |
5706319 | Holtz | Jan 1998 | A |
5714299 | Combes et al. | Feb 1998 | A |
5725987 | Combes et al. | Mar 1998 | A |
5726211 | Hedrick et al. | Mar 1998 | A |
5730874 | Wai et al. | Mar 1998 | A |
5736425 | Smith et al. | Apr 1998 | A |
5739223 | DeSimone | Apr 1998 | A |
5746008 | Yamashita et al. | May 1998 | A |
5766367 | Smith et al. | Jun 1998 | A |
5769588 | Toshima et al. | Jun 1998 | A |
5783082 | DeSimone et al. | Jul 1998 | A |
5797719 | James et al. | Aug 1998 | A |
5798126 | Fujikawa et al. | Aug 1998 | A |
5798438 | Sawan et al. | Aug 1998 | A |
5804607 | Hedrick et al. | Sep 1998 | A |
5807607 | Smith et al. | Sep 1998 | A |
5817178 | Mita et al. | Oct 1998 | A |
5847443 | Cho et al. | Dec 1998 | A |
5866005 | DeSimone et al. | Feb 1999 | A |
5868856 | Douglas et al. | Feb 1999 | A |
5868862 | Douglas et al. | Feb 1999 | A |
5872061 | Lee et al. | Feb 1999 | A |
5872257 | Beckman et al. | Feb 1999 | A |
5873948 | Kim | Feb 1999 | A |
5881577 | Sauer et al. | Mar 1999 | A |
5882165 | Maydan et al. | Mar 1999 | A |
5888050 | Fitzgerald et al. | Mar 1999 | A |
5893756 | Berman et al. | Apr 1999 | A |
5896870 | Huynh et al. | Apr 1999 | A |
5898727 | Fujikawa et al. | Apr 1999 | A |
5900107 | Murphy et al. | May 1999 | A |
5900354 | Batchelder | May 1999 | A |
5904737 | Preston et al. | May 1999 | A |
5906866 | Webb | May 1999 | A |
5908510 | McCullough et al. | Jun 1999 | A |
5928389 | Jevtic | Jul 1999 | A |
5932100 | Yager et al. | Aug 1999 | A |
5934856 | Asakawa et al. | Aug 1999 | A |
5934991 | Rush | Aug 1999 | A |
5944996 | DeSimone et al. | Aug 1999 | A |
5955140 | Smith et al. | Sep 1999 | A |
5965025 | Wai et al. | Oct 1999 | A |
5975492 | Brenes | Nov 1999 | A |
5976264 | McCullough et al. | Nov 1999 | A |
5979306 | Fujikawa et al. | Nov 1999 | A |
5980648 | Adler | Nov 1999 | A |
5981399 | Kawamura et al. | Nov 1999 | A |
5989342 | Ikeda et al. | Nov 1999 | A |
5992680 | Smith | Nov 1999 | A |
5994696 | Tai et al. | Nov 1999 | A |
6005226 | Aschner et al. | Dec 1999 | A |
6017820 | Ting et al. | Jan 2000 | A |
6021791 | Dryer et al. | Feb 2000 | A |
6024801 | Wallace et al. | Feb 2000 | A |
6029371 | Kamikawa et al. | Feb 2000 | A |
6035871 | Eui-Yeol | Mar 2000 | A |
6037277 | Masakara et al. | Mar 2000 | A |
6053348 | Morch | Apr 2000 | A |
6056008 | Adams et al. | May 2000 | A |
6063714 | Smith et al. | May 2000 | A |
6067728 | Farmer et al. | May 2000 | A |
6077053 | Fujikawa et al. | Jun 2000 | A |
6077321 | Adachi et al. | Jun 2000 | A |
6082150 | Stucker | Jul 2000 | A |
6085935 | Malchow et al. | Jul 2000 | A |
6097015 | McCullough et al. | Aug 2000 | A |
6099619 | Lansbarkis et al. | Aug 2000 | A |
6100198 | Grieger et al. | Aug 2000 | A |
6110232 | Chen et al. | Aug 2000 | A |
6114044 | Houston et al. | Sep 2000 | A |
6122566 | Nguyen et al. | Sep 2000 | A |
6128830 | Bettcher et al. | Oct 2000 | A |
6140252 | Cho et al. | Oct 2000 | A |
6145519 | Konishi et al. | Nov 2000 | A |
6149828 | Vaartstra | Nov 2000 | A |
6159295 | Maskara et al. | Dec 2000 | A |
6164297 | Kamikawa | Dec 2000 | A |
6171645 | Smith et al. | Jan 2001 | B1 |
6186722 | Shirai | Feb 2001 | B1 |
6200943 | Romack et al. | Mar 2001 | B1 |
6203582 | Berner et al. | Mar 2001 | B1 |
6216364 | Tanaka et al. | Apr 2001 | B1 |
6224774 | DeSimone et al. | May 2001 | B1 |
6228563 | Starov et al. | May 2001 | B1 |
6228826 | DeYoung et al. | May 2001 | B1 |
6232238 | Chang et al. | May 2001 | B1 |
6232417 | Rhodes et al. | May 2001 | B1 |
6235634 | White et al. | May 2001 | B1 |
6239038 | Wen | May 2001 | B1 |
6241825 | Wytman | Jun 2001 | B1 |
6242165 | Vaartstra | Jun 2001 | B1 |
6244121 | Hunter | Jun 2001 | B1 |
6251250 | Keigler | Jun 2001 | B1 |
6255732 | Yokoyama et al. | Jul 2001 | B1 |
6270531 | DeYoung et al. | Aug 2001 | B1 |
6270948 | Sato et al. | Aug 2001 | B1 |
6277753 | Mullee et al. | Aug 2001 | B1 |
6284558 | Sakamoto | Sep 2001 | B1 |
6286231 | Bergman et al. | Sep 2001 | B1 |
6305677 | Lenz | Oct 2001 | B1 |
6306564 | Mullee | Oct 2001 | B1 |
6319858 | Lee et al. | Nov 2001 | B1 |
6331487 | Koch | Dec 2001 | B2 |
6334266 | Moritz et al. | Jan 2002 | B1 |
6344174 | Miller et al. | Feb 2002 | B1 |
6344243 | McClain et al. | Feb 2002 | B1 |
6355072 | Racette et al. | Mar 2002 | B1 |
6358673 | Namatsu | Mar 2002 | B1 |
6361696 | Spiegelman et al. | Mar 2002 | B1 |
6367491 | Marshall et al. | Apr 2002 | B1 |
6380105 | Smith et al. | Apr 2002 | B1 |
6388317 | Reese | May 2002 | B1 |
6389677 | Lenz | May 2002 | B1 |
6418956 | Bloom | Jul 2002 | B1 |
6425956 | Cotte et al. | Jul 2002 | B1 |
6436824 | Chooi et al. | Aug 2002 | B1 |
6451510 | Messick et al. | Sep 2002 | B1 |
6454519 | Toshima et al. | Sep 2002 | B1 |
6454945 | Weigl et al. | Sep 2002 | B1 |
6458494 | Song et al. | Oct 2002 | B2 |
6461967 | Wu et al. | Oct 2002 | B2 |
6464790 | Sherstinsky et al. | Oct 2002 | B1 |
6465403 | Skee | Oct 2002 | B1 |
6472334 | Ikakura et al. | Oct 2002 | B2 |
6479407 | Yokoyama et al. | Nov 2002 | B2 |
6485895 | Choi et al. | Nov 2002 | B1 |
6486078 | Rangarajan et al. | Nov 2002 | B1 |
6492090 | Nishi et al. | Dec 2002 | B2 |
6500605 | Mullee et al. | Dec 2002 | B1 |
6503837 | Chiou | Jan 2003 | B2 |
6508259 | Tseronis et al. | Jan 2003 | B1 |
6509136 | Goldfarb et al. | Jan 2003 | B1 |
6509141 | Mullee | Jan 2003 | B2 |
6521466 | Castrucci | Feb 2003 | B1 |
6537916 | Mullee et al. | Mar 2003 | B2 |
6541278 | Morita et al. | Apr 2003 | B2 |
6546946 | Dunmire | Apr 2003 | B2 |
6550484 | Gopinath et al. | Apr 2003 | B1 |
6554507 | Namatsu | Apr 2003 | B2 |
6558475 | Simons et al. | May 2003 | B1 |
6561213 | Wang et al. | May 2003 | B2 |
6561220 | McCullough et al. | May 2003 | B2 |
6561481 | Filonczuk | May 2003 | B1 |
6561767 | Berger et al. | May 2003 | B2 |
6562146 | DeYoung et al. | May 2003 | B1 |
6564826 | Shen | May 2003 | B2 |
6565764 | Hiraoka et al. | May 2003 | B2 |
6576138 | Sateria et al. | Jun 2003 | B2 |
6583067 | Chang et al. | Jun 2003 | B2 |
6596093 | DeYoung et al. | Jul 2003 | B2 |
6613157 | DeYoung et al. | Sep 2003 | B2 |
6623355 | McClain et al. | Sep 2003 | B2 |
6635565 | Wu et al. | Oct 2003 | B2 |
6635582 | Yun et al. | Oct 2003 | B2 |
6641678 | DeYoung et al. | Nov 2003 | B2 |
6656666 | Taft et al. | Dec 2003 | B2 |
6669916 | Heim et al. | Dec 2003 | B2 |
6673521 | Moreau et al. | Jan 2004 | B2 |
6677244 | Ono et al. | Jan 2004 | B2 |
6685903 | Wong et al. | Feb 2004 | B2 |
6737725 | Grill et al. | May 2004 | B2 |
6748966 | Dvorak | Jun 2004 | B1 |
6764552 | Joyce et al. | Jul 2004 | B1 |
6777312 | Yang et al. | Aug 2004 | B2 |
6780765 | Goldstein | Aug 2004 | B2 |
6802961 | Jackson | Oct 2004 | B2 |
6846789 | Davenhall et al. | Jan 2005 | B2 |
6926798 | Biberger et al. | Aug 2005 | B2 |
20020001929 | Biberger et al | Jan 2002 | A1 |
20020046707 | Biberger et al. | Apr 2002 | A1 |
20020117391 | Beam | Aug 2002 | A1 |
20030003762 | Cotte et al. | Jan 2003 | A1 |
20030013311 | Chang et al. | Jan 2003 | A1 |
20030045117 | Cotte et al. | Mar 2003 | A1 |
20030047533 | Reid et al. | Mar 2003 | A1 |
20030106573 | Masuda et al. | Jun 2003 | A1 |
20030116176 | Rothman et al. | Jun 2003 | A1 |
20030125225 | Xu et al. | Jul 2003 | A1 |
20030196679 | Cotte et al. | Oct 2003 | A1 |
20040003828 | Jackson | Jan 2004 | A1 |
20040020518 | DeYoung et al. | Feb 2004 | A1 |
20040045588 | DeYoung et al. | Mar 2004 | A1 |
20040050406 | Sehgal | Mar 2004 | A1 |
20040087457 | Korzenski et al. | May 2004 | A1 |
20040103922 | Inoue et al. | Jun 2004 | A1 |
20040112402 | Simons et al. | Jun 2004 | A1 |
20040112409 | Schilling | Jun 2004 | A1 |
20040171502 | Clark et al. | Sep 2004 | A1 |
20040177867 | Schilling | Sep 2004 | A1 |
20040266635 | Korzenski et al. | Dec 2004 | A1 |
20050006310 | Agrawal et al. | Jan 2005 | A1 |
20050245409 | Cernat et al. | Nov 2005 | A1 |
Number | Date | Country |
---|---|---|
251213 | Aug 1948 | CH |
1399790 | Feb 2003 | CN |
36 08 783 | Sep 1987 | DE |
39 04 514 | Mar 1990 | DE |
40 04 111 | Aug 1990 | DE |
39 06 724 | Sep 1990 | DE |
39 06 735 | Sep 1990 | DE |
39 06 737 | Sep 1990 | DE |
44 29 470 | Mar 1995 | DE |
43 44 021 | Jun 1995 | DE |
198 60 084 | Jul 2000 | DE |
0 244 951 | Nov 1987 | EP |
02 72 141 | Jun 1988 | EP |
0 283 740 | Sep 1988 | EP |
0 302 345 | Feb 1989 | EP |
0 370 233 | May 1990 | EP |
0 391 035 | Oct 1990 | EP |
0 453 867 | Oct 1991 | EP |
0 518 653 | Dec 1992 | EP |
0 536 752 | Apr 1993 | EP |
0 572 913 | Dec 1993 | EP |
0 587 168 | Mar 1994 | EP |
0 620 270 | Oct 1994 | EP |
0 679 753 | Nov 1995 | EP |
0 711 864 | May 1996 | EP |
0 726 099 | Aug 1996 | EP |
0 727 711 | Aug 1996 | EP |
0 822 583 | Feb 1998 | EP |
0 829 312 | Mar 1998 | EP |
0 836 895 | Apr 1998 | EP |
0 903 775 | Mar 1999 | EP |
1 499 491 | Sep 1967 | FR |
2 003 975 | Mar 1979 | GB |
2 193 482 | Feb 1988 | GB |
60-192333 | Sep 1985 | JP |
60-2348479 | Nov 1985 | JP |
60-246635 | Dec 1985 | JP |
61-017151 | Jan 1986 | JP |
61-231166 | Oct 1986 | JP |
62-111442 | May 1987 | JP |
62-099619 | Jun 1987 | JP |
63-256326 | Oct 1988 | JP |
63-303059 | Dec 1988 | JP |
1-045131 | Feb 1989 | JP |
1-246835 | Oct 1989 | JP |
2-148841 | Jun 1990 | JP |
2-209729 | Aug 1990 | JP |
2-304941 | Dec 1990 | JP |
4-284648 | Oct 1992 | JP |
7-142333 | Jun 1995 | JP |
8-186140 | Jul 1996 | JP |
8-222508 | Aug 1996 | JP |
10-144757 | May 1998 | JP |
56-142629 | Nov 1998 | JP |
10335408 | Dec 1998 | JP |
11-200035 | Jul 1999 | JP |
2000-106358 | Apr 2000 | JP |
WO 8707309 | Dec 1987 | WO |
WO 9006189 | Jun 1990 | WO |
WO 9013675 | Nov 1990 | WO |
WO 9112629 | Aug 1991 | WO |
WO 9314255 | Jul 1993 | WO |
WO 9314259 | Jul 1993 | WO |
WO 9320116 | Oct 1993 | WO |
WO 9627704 | Sep 1996 | WO |
WO 9918603 | Apr 1999 | WO |
WO 9949998 | Oct 1999 | WO |
WO 0036635 | Jun 2000 | WO |
WO 0073241 | Dec 2000 | WO |
WO 0110733 | Feb 2001 | WO |
WO 0133613 | May 2001 | WO |
WO 0133615 | May 2001 | WO |
WO 0155628 | Aug 2001 | WO |
WO 0168279 | Sep 2001 | WO |
WO 0174538 | Oct 2001 | WO |
WO 0178911 | Oct 2001 | WO |
WO 0185391 | Nov 2001 | WO |
WO 0194782 | Dec 2001 | WO |
WO 0209894 | Feb 2002 | WO |
WO 0211191 | Feb 2002 | WO |
WO 0215251 | Feb 2002 | WO |
WO 0216051 | Feb 2002 | WO |
WO 03030219 | Oct 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20060180573 A1 | Aug 2006 | US |